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Background
Chemotherapy-induced diarrhea is a common problem,
with pain, ulceration, bloating, vomiting and diarrhea
occurring in about 40% of patients on a standard regimen
and dose [1]. The pathophysiology of this problem is
quite complex, involving multiple pathways including
increases in pro-inflammatory mediators tumor necrosis
factor- alpha (TNF-a) and interleukin-6 (lL-6) [2].
Serum-derived bovine immunoglobulin (SBI) has been
used for years; first as a valued feed ingredient for
weaned pigs where it has been shown to decrease mortal-
ity and morbidity and increase growth rates [3]; and then
as a safe dietary supplement in humans [4]. In experi-
mental animal models, SBI has been found to decrease
both TNF -a and lL-6 in intestinal inflammation, and
decrease intestinal permeability [5].
Case history
This patient is a white female, 54 years of age, who devel-
oped a renal cell carcinoma and an unrelated adenocarci-
noma of the ovary. She underwent a nephrectomy,
empiric lymph node dissection, omentectomy, and bilat-
eral salpingo-oophrectomy. A 6-week course of carbopla-
tin and paclitaxel was prescribed for the treatment of the
carcinoma of the ovary. Consistent with previous reports,
this treatment regimen induced abdominal pain, nausea,
vomiting, and diarrhea; resulting in a 12 kilogram weight
loss. With the physician’s approval, she began using 2 g of
SBI b.i.d as a food supplement.
Results
After using SBI, this patient’s symptoms improved while
she continued with chemotherapy. She gained 2.5 kilo-
grams in the next 2 weeks, without side effects from SBI
and was able to successfully complete her course of che-
motherapy. SBI has previously been shown to decrease
diarrhea and, recently, has been shown to decrease intest-
inal permeability [6].
Conclusions
SBI may have improved this patient’s gastrointestinal
complaints and maintenance of body weight. Clinical
and nonclinical studies are warranted to determine the
efficacy of this food product in decreasing the side
effects associated with chemotherapy treatment.
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